Table 2.
Adverse reaction after COVID-19 vaccine administration among health care professionals in Addis Ababa, Ethiopia.
| No | Adverse reactions following COVID-19 | Frequency |
|---|---|---|
| 1. | Did you experience any adverse reactions? | |
| Yes | 142 (51.3%) | |
| No | 135 (48.7%) | |
| 2. | Adverse reactions experienced after vaccine administration | |
| Injection site pain | 151 (54.5%) | |
| Headache | 114 (41.2%) | |
| Fever | 104 (37.5%) | |
| Fatigability and tiredness | 94 (33.9%), | |
| Chills | 92 (33.2%) | |
| Muscle pain | 79 (28.5%) | |
| Decreased sleep quality | 34 (12.3%) | |
| Nausea and vomiting | 24 (8.7%) | |
| Irritation and skin reaction | 19 (6.9%) | |
| Body sweating | 12 (4.3%) | |
| Runny nose | 25 (9%) | |
| Dyspnea | 8 (2.9%) | |
| Chest pain | 14 (5.1%) | |
| Sore throat | 21 (7.6%) | |
| Cough | 28 (10.1%) | |
| 3. | How soon the symptoms appeared after injection with a COVID-19 vaccine | |
| Up to 4 h | 17 (6.1%) | |
| 5–8 h | 70 (25.3%) | |
| 9–12 h | 41 (14.8%) | |
| After 24 h | 14 (5.1%) | |
| 4. | How long the symptoms lasted | |
| Less than 1 day | 29 (10.5%) | |
| 1–3 days | 79 (28.5%) | |
| 4–7 days | 34 (12.3%) | |
| More than 7 days | 0 | |
| 5. | Have you been diagnosed with any types of thrombosis (blood clots)? | |
| Yes | 2 (1.4%) | |
| No | 140 (98.6%) | |
| 6. | Would you recommend the vaccine that you received to others? | |
| Yes | 245 (88.4%) | |
| No | 32 (11.6%) |